Ad5-triCoV/Mac

N/A

Report date: 2022/12/16 15:21:55

Base Information

Drug NameAd5-triCoV/Mac
Drug Alias NameAd5-triCoV/Mac
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionCoronavirus spike glycoprotein inhibitorsRNA-directed RNA polymerase inhibitors
TargetsCoronavirus spike glycoproteinRNA-directed RNA polymerase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCanadian Institutes Of Health Research (Cihr)Mcmaster University
China Registration ClassN/A

Develop Information

Active CompaniesCanadian Institutes Of Health Research (Cihr)Mcmaster University
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A